AlphaGrep UK’s Halozyme HALO Stock Holding History

AlphaGrep UK’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4,348	Closed	-$340K	–	849
2026 Q2	$340K	Buy	+4,348	New	+$296K	0.1%	402
2026 Q1	–	Sell	-3,128	Closed	-$211K	–	851
2025 Q4	$211K	Buy	+3,128	New	+$210K	0.07%	609

Other funds holding HALO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

AlphaGrep UK's HALO Position: Q3 2026 in Review

AlphaGrep UK sold out of Halozyme (HALO) in Q3 2026, closing a stake of 4,348 shares — an estimated $340K sold.

AlphaGrep UK first reported a position in HALO in Q4 2025 and held it in 2 quarters. The position peaked at $340K in Q2 2026. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

AlphaGrep UK reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 4,348 Halozyme shares in Q3 2026, an estimated $340K.
AlphaGrep UK first reported a position in Halozyme in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Halozyme position peaked at $340K in Q2 2026.
636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.